Keywords: Mylan, EPS, RESULTS,ROBERT COURY,

Mylan sees 2nd-qtr 2011 adjusted EPS rocket 41%

Article | 27 July 2011

Print This

US generics drug major Mylan (Nasdaq: MYL) announced its financial results for the three months ended June 30, 2011 showing that adjusted ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in